• No results found

therapeutic agents

Histone Deacetylase Inhibitors As Potential Therapeutic Agents For Various Disorders

Histone Deacetylase Inhibitors As Potential Therapeutic Agents For Various Disorders

... Histone Deacetylase Inhibitors As Potential Therapeutic Agents For Various Disorderst restrains transcription of gene by controlling the penetrability of transcription.. factors [r] ...

19

INDIAN TINOSPORA SPECIES:  NATURAL IMMUNOMODULATORS AND THERAPEUTIC AGENTS

INDIAN TINOSPORA SPECIES: NATURAL IMMUNOMODULATORS AND THERAPEUTIC AGENTS

... The substance which stimulates or suppresses the components of immune system is known as immunomodulator. Antibiotics have limited effective life span and its prolonged use is harmful. So, scientists are more relying on ...

9

Corticosteroids as Primary Therapeutic Agents in Respiratory Distress Syndrome (RDS)

Corticosteroids as Primary Therapeutic Agents in Respiratory Distress Syndrome (RDS)

... Corticosteroids as Primary Therapeutic Agents in Respiratory Distress Syndrome. http://pediatrics.aappublications.org/content/51/5/952[r] ...

5

Heat shock proteins in health and disease: therapeutic targets or therapeutic agents?

Heat shock proteins in health and disease: therapeutic targets or therapeutic agents?

... There are clearly many aspects of heat shock protein biology that remain puzzling. On the one hand, reactivity to heat shock proteins appears to be associated with several pathological disease states, yet, on the other ...

22

Thymic cells and humoral factors as therapeutic agents

Thymic cells and humoral factors as therapeutic agents

... transplantation and thymosin injections in similar patients (Table I). In patients with thymic hypo plasia and the presence of thymic precursor cells, fetal thymus transplantation may re[r] ...

6

Emerging therapeutic agents for genitourinary cancers

Emerging therapeutic agents for genitourinary cancers

... UC is the ninth most frequently diagnosed cancer world- wide, ranks 13th in death ranks, and is the most com- mon cancer of the GU system [5, 6]. The median age of diagnosis is 73 years making bladder cancer a disease of ...

25

Emerging therapeutic agents for lung cancer

Emerging therapeutic agents for lung cancer

... was quickly followed by crizotinib, which was initially developed as a MET (mesenchymal-to-epithelial transi- tion/hepatocyte growth factor receptor) inhibitor and was found to be highly active against small subset of ...

14

THERAPEUTIC AGENTS FOR REDUCTION OF INTRACRANIAL PRESSURE

THERAPEUTIC AGENTS FOR REDUCTION OF INTRACRANIAL PRESSURE

... Although in ordinary clinical situations the decrease in pressure of the cerebro- spinal fluid is proportional to urine output, the reduction in cerebral swelling is[r] ...

5

New and emerging therapeutic agents for the treatment of fibromyalgia: an update

New and emerging therapeutic agents for the treatment of fibromyalgia: an update

... preceded by a 1-week baseline phase, and followed by a 6-week open-label phase to determine optimal dosage (300, 450, 600 mg/day) and detect “responders” (those with 50% reduction in pain VAS score from open-label ...

15

Salts of Therapeutic Agents: Chemical,

Salts of Therapeutic Agents: Chemical,

... For example, sodium, potassium and free acid form of diclofenac are approved as oral medications. 255[r] ...

14

Novel therapeutic agents for cutaneous T-Cell lymphoma

Novel therapeutic agents for cutaneous T-Cell lymphoma

... Pralatrexate (PDX, 10-propargyl 10-deazaaminopterin), a novel antifolate designed to have high affinity for the reduced folate carrier (RFC) was approved for the treat- ment of relapsed or refractory PTCL in September ...

15

Current and developing therapeutic agents in the treatment of Chagas disease

Current and developing therapeutic agents in the treatment of Chagas disease

... Recently, it has been demonstrated that patients with chronic Chagas disease treated with itraconazole or allopurinol who did not respond to the specific therapy (there was no parasit[r] ...

11

Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy

Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy

... potential therapeutic agents that have been studied for the prevention and/or inhibition of mucositis induced by conventional chemotherapy and radiotherapy according to their mechanisms of ...

10

Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy

Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy

... of therapeutic agents, especially small molecular agents such as radioisotope che- lates, is rapid elimination of the agents and their widespread distributions into normal organs and ...

12

Vol 29, No 1 (2019)

Vol 29, No 1 (2019)

... Standard systemic therapeutic agents used for acne treatment include oral antimicrobials, isotretinoin and hormonal agents. 7 Despite advances in acne therapy in recent years, treatment failures and ...

9

Nanoparticles in Drug Delivery and Cancer Therapy: The Giant Rats Tail

Nanoparticles in Drug Delivery and Cancer Therapy: The Giant Rats Tail

... cer agents and encapsulated with biocompatible polymer represent a potential platform to deliver tumor targeted drugs and document the delivery process ...for therapeutic pharmaceuticals such as liposomal ...

10

Optimization of monoclonal antibodies purification expressed in H-192 cells using preparative native-polyacrylamide gel electrophoresis

Optimization of monoclonal antibodies purification expressed in H-192 cells using preparative native-polyacrylamide gel electrophoresis

... pivotal therapeutic agents in the pharmaceutical industry, having applications in diagnostics and therapeutic areas because of their high specificity ...

5

Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease

Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease

... other agents that stimulate autophagy, in- cluding metformin and trehalose ...these agents is lim- ited, while upstream ALP components are involved in many other pathways than ...several agents that ...

18

Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions

Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions

... formulations of classic agents or drugs targeting the desmoplastic and hypoxic environment were developed. A randomized phase III study NAPOLI-1 added nanoli- posome irinotecan prior to 5-FU/leucovorin (LV) in ...

17

Chemotherapy for second-stage Human African trypanosomiasis (Review)

Chemotherapy for second-stage Human African trypanosomiasis (Review)

... Diagnosis and stage determination of HAT are problematic and cannot be based on clinical signs alone (Lejon 2005). The presence of parasites has to be demonstrated in body fluids, and, according to the World Health ...

48

Show all 10000 documents...

Related subjects